Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 4
1955 3
1956 26
1957 39
1958 37
1959 31
1960 16
1961 22
1962 51
1963 37
1964 38
1965 28
1966 36
1967 31
1968 35
1969 29
1970 31
1971 57
1972 55
1973 76
1974 85
1975 101
1976 87
1977 78
1978 71
1979 101
1980 79
1981 77
1982 73
1983 83
1984 89
1985 82
1986 88
1987 73
1988 93
1989 93
1990 61
1991 94
1992 73
1993 88
1994 76
1995 90
1996 100
1997 108
1998 121
1999 151
2000 144
2001 170
2002 222
2003 204
2004 214
2005 265
2006 311
2007 364
2008 368
2009 385
2010 380
2011 403
2012 428
2013 487
2014 467
2015 418
2016 431
2017 447
2018 392
2019 388
2020 387
2021 387
2022 317
2023 312
2024 153

Text availability

Article attribute

Article type

Publication date

Search Results

10,320 results

Results by year

Filters applied: . Clear all
Page 1
An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations.
Shellenberg TP, Stoops WW, Lile JA, Rush CR. Shellenberg TP, et al. Expert Rev Clin Pharmacol. 2020 Aug;13(8):825-833. doi: 10.1080/17512433.2020.1796636. Epub 2020 Jul 25. Expert Rev Clin Pharmacol. 2020. PMID: 32715789 Review.
INTRODUCTION: Methylphenidate remains a first-line medication for treating ADHD in children and adults. ...The development of abuse deterrent formulations of methylphenidate is warranted....
INTRODUCTION: Methylphenidate remains a first-line medication for treating ADHD in children and adults. ...The development of abuse d …
Pharmacokinetics and clinical effectiveness of methylphenidate.
Kimko HC, Cross JT, Abernethy DR. Kimko HC, et al. Clin Pharmacokinet. 1999 Dec;37(6):457-70. doi: 10.2165/00003088-199937060-00002. Clin Pharmacokinet. 1999. PMID: 10628897 Review.
Methylphenidate is administered as a racemic mixture that undergoes stereoselective clearance. ...Methylphenidate is efficacious for short term treatment for children with ADHD. ...
Methylphenidate is administered as a racemic mixture that undergoes stereoselective clearance. ...Methylphenidate is efficacio …
Misuse of Methylphenidate.
Clemow DB. Clemow DB. Curr Top Behav Neurosci. 2017;34:99-124. doi: 10.1007/7854_2015_426. Curr Top Behav Neurosci. 2017. PMID: 26695166 Review.
Regardless, methylphenidate is an important treatment option, and detecting malingering for the purpose of illicit access to methylphenidate for subsequent misuse or diversion is a difficult challenge. Also discussed are the effects of methylphenidate in pati …
Regardless, methylphenidate is an important treatment option, and detecting malingering for the purpose of illicit access to methy …
[Methylphenidate].
Tagaya H, Murayama N, Fukase Y. Tagaya H, et al. Nihon Rinsho. 2015 Sep;73(9):1511-5. Nihon Rinsho. 2015. PMID: 26394513 Review. Japanese.
Methylphenidate enhances dopaminergic neurotransmission in the central nervous system. ...Growing number of illegal trades of methylphenidate and medical complications caused by misuse of methylphenidate urged Japanese government to introduce regulations limi …
Methylphenidate enhances dopaminergic neurotransmission in the central nervous system. ...Growing number of illegal trades of meth …
[Methylphenidate misuse].
Bruggisser M, Bodmer M, Liechti ME. Bruggisser M, et al. Praxis (Bern 1994). 2012 Feb 29;101(5):299-305. doi: 10.1024/1661-8157/a000856. Praxis (Bern 1994). 2012. PMID: 22377977 Review. German.
Methylphenidate (MPH) is mainly used for treatment of the attention-deficit hyperactivity syndrome (ADHS). ...Methylphenidate is also misused in combination with other drugs. Patients with ADHD are also at risk to misuse their prescribed methylphenidate medic …
Methylphenidate (MPH) is mainly used for treatment of the attention-deficit hyperactivity syndrome (ADHS). ...Methylphenidate …
Use of cognitive enhancers: methylphenidate and analogs.
Carlier J, Giorgetti R, Varì MR, Pirani F, Ricci G, Busardò FP. Carlier J, et al. Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):3-15. doi: 10.26355/eurrev_201901_16741. Eur Rev Med Pharmacol Sci. 2019. PMID: 30657540 Free article. Review.
We aimed to review the use and misuse of methylphenidate and analogs, and the risk associated. Moreover, we exhaustively reviewed the scientific data on the most recent methylphenidate analogs (methylphenidate and ethylphenidate excluded). MATERIALS AND METHO …
We aimed to review the use and misuse of methylphenidate and analogs, and the risk associated. Moreover, we exhaustively reviewed the …
Methylphenidate-Induced Menorrhagia in Twin Girls.
Özdağ V, Koyuncu O, Özdemir YE, Tanir Y. Özdağ V, et al. Iran J Psychiatry. 2022 Oct;17(4):476-479. doi: 10.18502/ijps.v17i4.10698. Iran J Psychiatry. 2022. PMID: 36817810 Free PMC article.
Thrombocytopenia, nasal bleeding and menstrual bleeding disorders are very rarely reported during methylphenidate use. One of the least expected side effects during methylphenidate usage is menorrhagia. ...To our knowledge, this is the first report of menorrhagia as …
Thrombocytopenia, nasal bleeding and menstrual bleeding disorders are very rarely reported during methylphenidate use. One of the lea …
Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.
Sugrue D, Bogner R, Ehret MJ. Sugrue D, et al. Am J Health Syst Pharm. 2014 Jul 15;71(14):1163-70. doi: 10.2146/ajhp130638. Am J Health Syst Pharm. 2014. PMID: 24973373 Review.
Dexmethylphenidate (the more pharmacologically active d-isomer of racemic methylphenidate) can provide efficacy comparable to that of IR methylphenidate at half the dose; an extended-release form of dexmethylphenidate can provide less fluctuation in peak and trough …
Dexmethylphenidate (the more pharmacologically active d-isomer of racemic methylphenidate) can provide efficacy comparable to that of …
Methylphenidate transdermal system: in attention-deficit hyperactivity disorder in adolescents.
Keating GM. Keating GM. CNS Drugs. 2011 Apr;25(4):333-42. doi: 10.2165/11206730-000000000-00000. CNS Drugs. 2011. PMID: 21425884 Review.
Methylphenidate transdermal system uses DOT Matrix technology and, once applied to the skin, releases methylphenidate continuously. ...Methylphenidate transdermal system was generally well tolerated in adolescents with ADHD. ...
Methylphenidate transdermal system uses DOT Matrix technology and, once applied to the skin, releases methylphenidate continuo …
10,320 results
You have reached the last available page of results. Please see the User Guide for more information.